Technologies
PDF


WARF: P06411US

Fast and Efficient Catalytic Metathesis of Secondary Amides for the Synthesis of Novel Molecules


INVENTORS -

Samuel Gellman, Denis Kissounko, Shannon Stahl, Christen Bell

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a method and reagents for the equilibrium-controlled catalytic metathesis of secondary amides.
OVERVIEWDynamic covalent chemistry (DCC) offers a powerful approach for the controlled synthesis of organic molecules with interesting structures and/or properties. It describes reactions that involve the exchange of functional groups, such as esters, thioesters, imines or disulfides, among reactants. 

Extending this approach to molecules that contain carboxamide groups would be useful, but carboxamide groups are not very reactive. Identifying catalysts that induce amide metathesis, a chemical reaction that involves the exchange of amide groups between reactants, has been challenging. 

The inventors previously developed methods of catalytic transamidation and amide metathesis under moderate conditions (see WARF reference number P03068US). Those methods involved a metal-catalyzed reaction that could be carried out at lower temperatures than previous methods.
THE INVENTIONUW-Madison researchers now have developed a different approach that allows catalytic transamidation and amide metathesis reactions to occur efficiently, quickly and at low temperatures. This approach uses imides to initiate the reactions. 

Specifically, this method involves reacting two or more distinct secondary amides in an aprotic solvent in the presence of a Bronsted base and an imide initiator. During the reaction, an acyl group exchange occurs between the secondary amides.
APPLICATIONS
  • Polymer manufacturing
  • Peptide synthesis for drug development
KEY BENEFITS
  • Provides a powerful approach for the thermodynamically-controlled synthesis of industrially useful molecules
  • Enables improved control of reaction rates
  • Reaction is fast and efficient and takes place at low temperatures.
  • Resulting molecules may have novel biological activity and therapeutic applications.
  • Provides a novel strategy for implementing amide-based DCC
ADDITIONAL INFORMATION
For More Information About the Inventors
Contact Information
For current licensing status, please contact Rafael Diaz at rdiaz@warf.org or 608-960-9847.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.